arrow_back Back to App

Drug Labeling Update: Enhanced Patient Safety

New regulations aim to ensure that safety information for generic drugs is quickly updated. This will provide citizens with access to the latest data on potential risks, increasing their safety when taking medications.
Key points
Generic drug manufacturers will be able to update labels faster to include new safety information.
These changes can be made even before official approval by relevant authorities, speeding up access to important warnings.
All generic drugs linked to a specific reference drug will be required to have consistent and up-to-date labels.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_4134
Sponsor: Rep. Schiff, Adam B. [D-CA-30]
Process start date: 2023-06-14
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Updated Drug Labeling for Patient Safety Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_4134.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-06-14.

What are the main provisions?

Key points include:

  • Generic drug manufacturers will be able to update labels faster to include new safety information.
  • These changes can be made even before official approval by relevant authorities, speeding up access to important warnings.
  • All generic drugs linked to a specific reference drug will be required to have consistent and up-to-date labels.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Schiff, Adam B. [D-CA-30].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health